Showing results (241-250 of 874) with videos related to

Sort By:
Pageof 88
Therapeutic Advances in Gastroenterology|January 28, 2021
Long-term effectiveness, safety and immunogenicity of the biosimilar SB2 in inflammatory bowel disease patients after switching from originator infliximabSarah Fischer, Sarah Cohnen, Entcho Klenske, et al.
Annals of the New York Academy of Sciences|October 15, 2013
The esophageal mucosa and submucosa: immunohistology in GERD and Barrett's esophagusHenry D Appelman, Catherine Streutker, Michael Vieth, et al.
Frontiers in Pharmacology|February 19, 2019
Cellular Mechanisms of Etrolizumab Treatment in Inflammatory Bowel DiseaseCharlotte Lichnog, Sha Klabunde, Emily Becker, et al.
Gastroenterology|July 29, 2019
Interferon Lambda Promotes Paneth Cell Death Via STAT1 Signaling in Mice and Is Increased in Inflamed Ileal Tissues of Patients With Crohn's DiseaseClaudia Günther, Barbara Ruder, Iris Stolzer, et al.
The Lancet. Gastroenterology & Hepatology|October 8, 2020
Cobitolimod for moderate-to-severe, left-sided ulcerative colitis (CONDUCT): a phase 2b randomised, double-blind, placebo-controlled, dose-ranging induction trialRaja Atreya, Laurent Peyrin-Biroulet, Andrii Klymenko, et al.
Gastroenterology|July 5, 2021
Targeting of the Tec Kinase ITK Drives Resolution of T Cell-Mediated Colitis and Emerges as Potential Therapeutic Option in Ulcerative ColitisKristina Lechner, Stefanie Mott, Ragheed Al-Saifi, et al.
Clinical and Translational Medicine|April 8, 2023
Anti-β7 integrin treatment impedes the recruitment on non-classical monocytes to the gut and delays macrophage-mediated intestinal wound healingKatrin Sommer, Karin Heidbreder, Lucas Kreiss, et al.
Inflammatory Bowel Diseases|April 1, 2014
Microscopic colitis and colorectal neoplastic lesion rate in chronic nonbloody diarrhea: a prospective, multicenter studyGian Eugenio Tontini, Luca Pastorelli, Luisa Spina, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 6, 2019
What gastroenterologists and hepatologists should know about organoids in 2019Claudia Günther, Teresa Brevini, Fotios Sampaziotis, et al.
Therapeutic Advances in Gastroenterology|December 2, 2024
Reverse switching from the biosimilar SB2 to the originator infliximab in previously switched patients with inflammatory bowel diseases: results of a prospective long-term cohort studySarah Fischer, Moritz Donhauser, Sarah Cohnen, et al.
Pageof 88